Circulating biomarkers for management of cancer therapeutics-related cardiac dysfunction

Cancer therapeutics-related cardiac dysfunction (CTRCD) has emerged as a major cause of morbidity and mortality in cancer survivors. Effective clinical management of CTRCD is impeded by a lack of sensitive diagnostic and prognostic strategies. Circulating molecular markers could potentially address...

Descripción completa

Detalles Bibliográficos
Autores principales: Tonry, Claire, Russell-Hallinan, Adam, McCune, Claire, Collier, Patrick, Harbinson, Mark, Dixon, Lana, Watson, Chris J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153425/
https://www.ncbi.nlm.nih.gov/pubmed/35640873
http://dx.doi.org/10.1093/cvr/cvac087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153425/
https://www.ncbi.nlm.nih.gov/pubmed/35640873
http://dx.doi.org/10.1093/cvr/cvac087

Ejemplares similares